Medication info
Simvastesterol Tablets 20 mg (Simvastatin)

Simvastesterol Tablets 20 mg (Simvastatin)

Prescription medicationTabletOral
Ingredient · strength
Simvastatin›20mg / 1 tablet
Manufacturer / importer
Daewoo Pharmaceutical Co., Ltd.
Appearance
Brownish-yellow oval film-coated tablets
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 200400682 · Notified 2004.11.12 · Insurance code 649601420

Summary

Main use
Improvement of hyperlipidemia and pediatric familial hypercholesterolemia; prevention of cardiovascular disease
Who takes it
Adults · Children
Adult dose
Patients must follow a standard cholesterol-lowering diet before and during treatment with this medicine. 1. Reduction of the risk of cardiovascular disease Adult patients at high risk of coronary heart disease events due to a history of coronary heart disease, diabetes, peripheral vascular disease, stroke, or other cerebrovascular disease The recommended initial dose is simvastatin 40 mg once daily. 2. Hyperlipidemia 1) Reduction of risk in patients with hypercholesterolemia and coronary heart disease, and hyperlipidemia The usual recommended initial dose is 20 mg of this medicine once daily in the evening. Patients with mild to moderate hypercholesterolemia may start with 10 mg of this medicine. A dose of 5 ~ 40 mg of this medicine once daily in the evening is recommended. Adjust the dose appropriately according to the initial LDL cholesterol level before treatment, the treatment goal, and the patient's response to the medicine. Measure cholesterol levels 4 weeks after starting treatment and periodically thereafter, and adjust the dose. Reduce the dose if the cholesterol level falls below the target level. Due to the increased risk of myopathy, including rhabdomyolysis, use of this medicine at a dose of 80 mg, particularly during the first year of treatment, is restricted to patients who have been taking 80 mg of this medicine for 12 months or more without evidence of muscle toxicity (see 1. Warnings under Precautions for Use). 2) For recommended doses in patients taking this medicine concomitantly with fibrates (excluding gemfibrozil and fenofibrate), amiodarone, verapamil, diltiazem, or amlodipine, and in certain patient groups (i.e., patients with homozygous familial hypercholesterolemia, elderly patients, and patients with renal impairment), see below (see 6. Interactions under Precautions for Use). (1) Use in patients with homozygous familial hypercholesterolemia Based on the results of controlled clinical trials, administer 40 mg of this medicine once daily in the evening to patients with homozygous familial hypercholesterolemia. Administer this medicine in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when other lipid-lowering treatments are unavailable. (2) In elderly patients, a daily dose of 20 mg of this medicine may achieve the maximum reduction in cholesterol levels. (3) Use in patients taking verapamil, diltiazem, or dronedarone When this medicine is administered concomitantly to patients taking verapamil, diltiazem, or dronedarone, the dose of this medicine should not exceed 10 mg daily. (4) Use in patients taking amiodarone, amlodipine, or ranolazine When this medicine is administered concomitantly to patients taking amiodarone, amlodipine, or ranolazine, the dose of this medicine should not exceed 20 mg daily. (5) Concomitant use with other lipid-lowering agents This medicine is effective when used alone or in combination with a bile acid sequestrant. When this medicine is administered concomitantly with a fibrate (excluding gemfibrozil (see 2. Do not administer to the following patients under Precautions for Use) and fenofibrate), the dose of this medicine should not exceed 10 mg daily. (6) Use in patients with renal impairment As this medicine is not extensively excreted by the kidneys, dose adjustment is not required in patients with mild to moderate renal impairment. However, in patients with severe renal impairment, initiate treatment at 5 mg daily and monitor carefully.
Child dose
10 ~ 17 years: The recommended initial dose is 10 mg of this medicine once daily in the evening. The recommended dose range is 10 ~ 40 mg daily, and the recommended maximum dose is 40 mg daily. Adjust the dose appropriately for each patient according to the recommended treatment goal. Allow an interval of 4 weeks or more between dose adjustments.

Ingredients

Manufacturer
Daewoo Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of hyperlipidemia and pediatric familial hypercholesterolemia; prevention of cardiovascular disease

  • Coronary artery disease
  • diabetes
  • peripheral vascular disease
  • stroke
  • other cerebrovascular diseases
  • hypercholesterolemia
  • dyslipidemia
  • dysbetalipoproteinemia
  • hypertriglyceridemia
  • familial heterozygous hypercholesterolemia
  • premature cardiovascular disease
View approved original text

This medication is used to reduce the risk of cardiovascular diseases. It decreases the risk of events related to coronary artery disease, such as heart attacks, in adults with a history of coronary artery disease, diabetes, peripheral vascular disease, and stroke, along with several complications associated with it. Additionally, it is utilized as an adjunct therapy to dietary measures in patients with hyperlipidemia, improving cholesterol and triglyceride levels to enhance vascular health. Notably, it helps effectively control cholesterol levels in pediatric patients with a family history or specific types of hypercholesterolemia. This medication is effective in maintaining overall cardiovascular health and lowering the risk of heart diseases.

How to take

Adult dose

Patients must follow a standard cholesterol-lowering diet before and during treatment with this medicine. 1. Reduction of the risk of cardiovascular disease Adult patients at high risk of coronary heart disease events due to a history of coronary heart disease, diabetes, peripheral vascular disease, stroke, or other cerebrovascular disease The recommended initial dose is simvastatin 40 mg once daily. 2. Hyperlipidemia 1) Reduction of risk in patients with hypercholesterolemia and coronary heart disease, and hyperlipidemia The usual recommended initial dose is 20 mg of this medicine once daily in the evening. Patients with mild to moderate hypercholesterolemia may start with 10 mg of this medicine. A dose of 5 ~ 40 mg of this medicine once daily in the evening is recommended. Adjust the dose appropriately according to the initial LDL cholesterol level before treatment, the treatment goal, and the patient's response to the medicine. Measure cholesterol levels 4 weeks after starting treatment and periodically thereafter, and adjust the dose. Reduce the dose if the cholesterol level falls below the target level. Due to the increased risk of myopathy, including rhabdomyolysis, use of this medicine at a dose of 80 mg, particularly during the first year of treatment, is restricted to patients who have been taking 80 mg of this medicine for 12 months or more without evidence of muscle toxicity (see 1. Warnings under Precautions for Use). 2) For recommended doses in patients taking this medicine concomitantly with fibrates (excluding gemfibrozil and fenofibrate), amiodarone, verapamil, diltiazem, or amlodipine, and in certain patient groups (i.e., patients with homozygous familial hypercholesterolemia, elderly patients, and patients with renal impairment), see below (see 6. Interactions under Precautions for Use). (1) Use in patients with homozygous familial hypercholesterolemia Based on the results of controlled clinical trials, administer 40 mg of this medicine once daily in the evening to patients with homozygous familial hypercholesterolemia. Administer this medicine in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when other lipid-lowering treatments are unavailable. (2) In elderly patients, a daily dose of 20 mg of this medicine may achieve the maximum reduction in cholesterol levels. (3) Use in patients taking verapamil, diltiazem, or dronedarone When this medicine is administered concomitantly to patients taking verapamil, diltiazem, or dronedarone, the dose of this medicine should not exceed 10 mg daily. (4) Use in patients taking amiodarone, amlodipine, or ranolazine When this medicine is administered concomitantly to patients taking amiodarone, amlodipine, or ranolazine, the dose of this medicine should not exceed 20 mg daily. (5) Concomitant use with other lipid-lowering agents This medicine is effective when used alone or in combination with a bile acid sequestrant. When this medicine is administered concomitantly with a fibrate (excluding gemfibrozil (see 2. Do not administer to the following patients under Precautions for Use) and fenofibrate), the dose of this medicine should not exceed 10 mg daily. (6) Use in patients with renal impairment As this medicine is not extensively excreted by the kidneys, dose adjustment is not required in patients with mild to moderate renal impairment. However, in patients with severe renal impairment, initiate treatment at 5 mg daily and monitor carefully.

Child dose

10 ~ 17 years: The recommended initial dose is 10 mg of this medicine once daily in the evening. The recommended dose range is 10 ~ 40 mg daily, and the recommended maximum dose is 40 mg daily. Adjust the dose appropriately for each patient according to the recommended treatment goal. Allow an interval of 4 weeks or more between dose adjustments.

Precautions

This medication can cause serious muscle-related side effects, such as myopathy and rhabdomyolysis. The risk is higher especially when taken in high doses, so consultation with a physician is necessary immediately if symptoms of muscle pain or weakness occur while taking high doses. This medication should not be used in certain patients. For example, patients who are allergic to the drug or its ingredients, those with severely impaired liver function, pregnant or breastfeeding women, and those taking certain strong medications should not use this medication. Patients with liver or kidney problems, hypothyroidism, hereditary muscle disorders, or severe myasthenia gravis should take this medication with special caution. Elderly and female patients may also be at higher risk for side effects. It is important to regularly monitor liver function and muscle condition while taking this medication. If symptoms of muscle pain, tenderness, or weakness appear, or signs of liver dysfunction arise, medical personnel should be informed immediately. This medication can interact with various other medications, so it is crucial to inform the physician if other drugs are being taken. The risk of muscle side effects may increase when used with CYP3A4 inhibitors or certain lipid-lowering medications, antibiotics, and antiviral agents. Women who are pregnant or planning to become pregnant should not take this medication, and if pregnancy is confirmed while taking it, it should be discontinued immediately. In children or adolescents, it may only be used limitedly depending on specific age and conditions, and it should not be used in children under 10 years of age. This medication may increase the risk of liver damage when consuming alcohol, so intake of alcohol should be avoided or limited. In case of overdose, general emergency measures should be taken as there is no specific antidote. Finally, this medication should be kept out of the reach of children and stored in its original container.

Side effects

  • myopathy
  • rhabdomyolysis
  • abdominal pain
  • weakness
  • constipation
  • diarrhea
  • dyspepsia
  • bloating
  • nausea
  • headache
Show 89 more
  • upper respiratory infection
  • swelling
  • atrial fibrillation
  • gastritis
  • diabetes
  • myalgia
  • insomnia
  • dizziness
  • bronchitis
  • sinusitis
  • eczema
  • urinary tract infection
  • muscle cramps
  • arthralgia
  • immune-mediated necrotizing myopathy
  • dysgeusia
  • extraocular movement disorders
  • facial paresis
  • tremors
  • sensory disturbances
  • peripheral neuropathy
  • peripheral nerve paralysis
  • mental disorders
  • anxiety
  • sleep disorders
  • nightmares
  • depression
  • cognitive impairment
  • myasthenia gravis
  • oculomotor weakness
  • hepatitis
  • liver dysfunction
  • jaundice
  • pancreatitis
  • liver failure
  • cholestatic jaundice
  • hepatic steatosis
  • cirrhosis
  • fulminant hepatic necrosis
  • liver cancer
  • anorexia
  • vomiting
  • alopecia
  • pruritus
  • skin changes
  • lichenoid drug eruption
  • gynecomastia
  • decreased libido
  • sexual dysfunction
  • progression of cataracts
  • ocular muscle paralysis
  • anemia
  • elevated aminotransferases
  • elevated ALP
  • elevated γ-GTP
  • elevated bilirubin
  • thyroid dysfunction
  • elevated serum creatine kinase
  • abnormal liver function tests
  • increased HbA1c
  • elevated fasting blood glucose levels
  • limb paraesthesia
  • tingling
  • cold sensation
  • muscle weakness
  • thrombocytopenia
  • lupus-like erythema
  • vasculitis
  • purpura
  • thrombocytopenic purpura
  • leukopenia
  • hemolytic anemia
  • positive antinuclear antibody
  • increased erythrocyte sedimentation rate
  • eosinophilia
  • arthritis
  • urticaria
  • photosensitivity
  • fever
  • chills
  • flushing
  • fatigue
  • dyspnea
  • toxic epidermal necrolysis
  • mucous membrane syndrome
  • erythema multiforme
  • interstitial lung disease
  • vomiting
  • mucoid stools

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in an airtight, tightly closed container, ideally at room temperature between 1 and 30 degrees Celsius. Storing it this way will help maintain the drug's effectiveness and prevent degradation.

Appearance and packaging

Appearance

Brownish-yellow oval film-coated tablets

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.